Bar graph shows prevalence of PCLs, in %. Age ranges(y) are on the x-axis and prevalence of PCLs in % is on the y-axis. The prevalence of PCLs increases with age range: ≤39 (text@1), 40-49 (text@2), 50-59 (text@3), 60-69 (text@4), 70-79 (text@5), ≥80 (text@6).

Among 21,651 asymptomatic adults screened with MRI, 6.3% had incidental pancreatic cystic lesions, with <1% ≥3 cm; risk increased with age, female sex, and certain medical or family histories. #PancreaticCysts #MRI

ja.ma/4sxRh8U

Ongoing Trials: A closer look at ECOG-ACRIN’s clinical trials for patients with pancreatic conditions For Pancreatic Cancer Awareness Month, we highlight two actively recruiting clinical trials for patients with pancreatic conditions

On #WorldPancreaticCancerDay 💜 we are shining a light on two @eaonc.bsky.social clinical trials aiming to improve outcomes for patients with #PancreaticCancer & #PancreaticCysts - EA2185 and EA2192/APOLLO. Learn more here 👉 bit.ly/pancreaticf25

AI Finally Diagnoses Pancreatic Cysts, Still Can’t Find Your Keys #ArtificialIntelligence #MedicalBreakthrough #PancreaticCysts #RobotDoctors #AIwins By: TheJestPress.com In a shocking blow to anyone who makes their living squinting at grainy scans and murmuring “hmmm,” artificial intelligence has achieved the impossible: accurately classifying pancreatic cysts—on purpose and not just by binge-watching WebMD. Scientists at the forefront of medical innovation unleashed the AI, named “Dr. CystoBot,” on thousands of murky pancreas images.

AI Finally Diagnoses Pancreatic Cysts, Still Can’t Find Your Keys

#ArtificialIntelligence #MedicalBreakthrough #PancreaticCysts #RobotDoctors #AIwins By: TheJestPress.com In a shocking blow to anyone who makes their living squinting at grainy scans and murmuring “hmmm,” artificial intelligence has…